232 related articles for article (PubMed ID: 24186076)
1. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.
Douma TN; Millan MJ; Boulay D; Griebel G; Verdouw PM; Westphal KG; Olivier B; Groenink L
Psychopharmacology (Berl); 2014 Apr; 231(7):1289-303. PubMed ID: 24186076
[TBL] [Abstract][Full Text] [Related]
2. Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activation.
Douma TN; Millan MJ; Verdouw PM; Oosting RS; Olivier B; Groenink L
Neuropharmacology; 2014 Apr; 79():66-74. PubMed ID: 24211652
[TBL] [Abstract][Full Text] [Related]
3. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF.
Groenink L; Dirks A; Verdouw PM; de Graaff M; Peeters BW; Millan MJ; Olivier B
Biol Psychiatry; 2008 Feb; 63(4):360-8. PubMed ID: 17716630
[TBL] [Abstract][Full Text] [Related]
4. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
Larrauri JA; Burke DA; Hall BJ; Levin ED
Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
[TBL] [Abstract][Full Text] [Related]
6. Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.
Sutherland JE; Conti LH
Neuropharmacology; 2011 Mar; 60(4):561-71. PubMed ID: 21185316
[TBL] [Abstract][Full Text] [Related]
7. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
[TBL] [Abstract][Full Text] [Related]
8. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.
Flandreau E; Risbrough V; Lu A; Ableitner M; Geyer MA; Holsboer F; Deussing JM
Psychoneuroendocrinology; 2015 Mar; 53():16-28. PubMed ID: 25575243
[TBL] [Abstract][Full Text] [Related]
10. Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: Reversal by blockade of CRF1 receptors.
Bijlsma EY; Hendriksen H; Baas JM; Millan MJ; Groenink L
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1733-43. PubMed ID: 26302762
[TBL] [Abstract][Full Text] [Related]
11. CRF
Verdouw PM; van Esterik JC; Peeters BW; Millan MJ; Groenink L
Pharmacol Biochem Behav; 2017 Mar; 154():11-19. PubMed ID: 28089628
[TBL] [Abstract][Full Text] [Related]
12. Dissociable effects of the
Lins BR; Marks WN; Phillips AG; Howland JG
Psychopharmacology (Berl); 2017 Apr; 234(7):1079-1091. PubMed ID: 28180960
[TBL] [Abstract][Full Text] [Related]
13. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
Conti LH
Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
[TBL] [Abstract][Full Text] [Related]
14. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating.
Vinkers CH; Risbrough VB; Geyer MA; Caldwell S; Low MJ; Hauger RL
Pharmacol Biochem Behav; 2007 Mar; 86(3):550-8. PubMed ID: 17324452
[TBL] [Abstract][Full Text] [Related]
15. Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.
Rajbhandari AK; Bakshi VP
Neuropharmacology; 2020 Aug; 172():108090. PubMed ID: 32360378
[TBL] [Abstract][Full Text] [Related]
16. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.
Dirks A; Groenink L; Westphal KG; Olivier JD; Verdouw PM; van der Gugten J; Geyer MA; Olivier B
Neuropsychopharmacology; 2003 Oct; 28(10):1790-8. PubMed ID: 12865891
[TBL] [Abstract][Full Text] [Related]
17. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
[TBL] [Abstract][Full Text] [Related]
18. The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.
Sutherland JE; Burian LC; Covault J; Conti LH
Pharmacol Biochem Behav; 2010 Dec; 97(2):227-38. PubMed ID: 20709096
[TBL] [Abstract][Full Text] [Related]
19. Predator Stress-Induced CRF Release Causes Enduring Sensitization of Basolateral Amygdala Norepinephrine Systems that Promote PTSD-Like Startle Abnormalities.
Rajbhandari AK; Baldo BA; Bakshi VP
J Neurosci; 2015 Oct; 35(42):14270-85. PubMed ID: 26490866
[TBL] [Abstract][Full Text] [Related]
20. CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice.
Khella R; Short JL; Malone DT
Psychopharmacology (Berl); 2014 Aug; 231(16):3071-87. PubMed ID: 24705902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
